News
Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.
The maker of Ozempic and Wegovy obesity drugs said some of the prices could come down, as President Trump called for ...
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results